David Graham, MPH, MD

Associate director
US Food and Drug Administration

Poster(s):

• (169) Identification of Obesity and Tobacco Use in Claims Compared to Electronic Health Record (EHR) Data
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (41) Α-1 Adrenergic Receptor Antagonists and Risk of Severe COVID-19
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (149) Inverse Probability Treatment Weighting Versus Propensity Score Matching in The Sentinel System: A Test Case
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (37) Natural History of COVID-19 Among US Nursing Home Residents Ages >65 Years: Vaccine Era
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (25) Nursing Home Facility Characteristics and Occurrence of Severe COVID-19 Outcomes Among U.S. Medicare Beneficiaries Ages 65 and Older in The Vaccine Era
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (290) Risk of Intentional Self Harm and Suicide Among 5-Alpha Reductase Inhibitor Users and Alpha-Blocker Users
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST